Buscar
-
Regulating the drugs market in the EU: the contradiction between safety, innovation and access to care
(Workshop INNOV-EQ, FR, BORDEAUX, 2011)Communication dans un congrès avec actes -
The EU's government of pharmaceuticals: Incompleteness embraced
(Taylor and Francis Inc., 2014)Chapitre d'ouvrage -
Delayed Recognition in Science: Different Causes of Sleeping and Awakening of Scientific Discoveries.
(8th Biennial Atlanta Conf. on Science & Innovation Policy, US, Atlanta)Communication dans un congrès avec actes -
How does regulation affect beliefs ? Stock Market valuation of Orphan Drug Regulatory Approvals
(2016-09-01)Document de travail - Pré-publication -
Impact of market exclusivity versus IP protection in fostering innovation for rare diseases
(EPIP conference, NL, MAASTRICHT, 2010)Communication dans un congrès avec actes -
Drug Safety scientometrics overview highlights public health issues.
(Int. Society of Scientometrics & Informetrics,, IT, Roma)Autre communication scientifique (congrès sans actes - poster - séminaire...) -
Impact of Health Technology Assessment on Innovation Diffusion: the case of techniques in Interventional Radiology.
(12th European Conference on Health Economics,, NL, Maastricht)Autre communication scientifique (congrès sans actes - poster - séminaire...) -
Medical literature imprinting by pharma ghost writing: a scientometric evaluation
(Int. Society of Scientometrics & Informetrics, TR, Istanbul)Autre communication scientifique (congrès sans actes - poster - séminaire...) -
Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer. A prospective multicentric study by the Association Aquitaine Gastro.
(Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology. vol. 29, n° 6-7, pp. 667-75, 2005)Article de revue -
Molecular Basis for Expression of Common and Rare Fragile Sites
(Molecular and Cellular Biology. vol. 23, n° 20, pp. 7143-7151, 2003-10-15)Article de revue